Ad is loading...
FULC
Price
$3.00
Change
-$0.31 (-9.34%)
Updated
Nov 15 closing price
102 days until earnings call
VRDN
Price
$20.14
Change
-$1.50 (-6.93%)
Updated
Nov 15 closing price
101 days until earnings call
Ad is loading...

FULC vs VRDN

Header iconFULC vs VRDN Comparison
Open Charts FULC vs VRDNBanner chart's image
Fulcrum Therapeutics
Price$3.00
Change-$0.31 (-9.34%)
Volume$1.28M
CapitalizationN/A
Viridian Therapeutics
Price$20.14
Change-$1.50 (-6.93%)
Volume$1.83M
CapitalizationN/A
FULC vs VRDN Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FULC vs. VRDN commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongSell and VRDN is a StrongSell.

COMPARISON
Comparison
Nov 17, 2024
Stock price -- (FULC: $3.01 vs. VRDN: $20.14)
Brand notoriety: FULC and VRDN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 66% vs. VRDN: 136%
Market capitalization -- FULC: $187.51M vs. VRDN: $1.6B
FULC [@Biotechnology] is valued at $187.51M. VRDN’s [@Biotechnology] market capitalization is $1.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileVRDN’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • VRDN’s FA Score: 0 green, 5 red.
According to our system of comparison, VRDN is a better buy in the long-term than FULC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while VRDN’s TA Score has 3 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 4 bearish.
  • VRDN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FULC is a better buy in the short-term than VRDN.

Price Growth

FULC (@Biotechnology) experienced а -13.90% price change this week, while VRDN (@Biotechnology) price change was -20.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FULC is expected to report earnings on Feb 27, 2025.

VRDN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($1.6B) has a higher market cap than FULC($188M). VRDN YTD gains are higher at: -7.530 vs. FULC (-55.481). FULC has higher annual earnings (EBITDA): -30.88M vs. VRDN (-224.78M). VRDN has more cash in the bank: 571M vs. FULC (274M). FULC has less debt than VRDN: FULC (9.65M) vs VRDN (21M). FULC has higher revenues than VRDN: FULC (81.6M) vs VRDN (288K).
FULCVRDNFULC / VRDN
Capitalization188M1.6B12%
EBITDA-30.88M-224.78M14%
Gain YTD-55.481-7.530737%
P/E RatioN/AN/A-
Revenue81.6M288K28,333%
Total Cash274M571M48%
Total Debt9.65M21M46%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
66
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCVRDN
RSI
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRDN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RALOX10.250.03
+0.29%
Lazard Real Assets Open
FRIFX12.19N/A
N/A
Fidelity Real Estate Income
SHXYX14.62-0.05
-0.34%
American Beacon Shapiro Equity Opps Y
CBARX47.04-0.60
-1.26%
Calvert Balanced R6
FICGX12.40-0.23
-1.82%
Cantor Fitzgerald Large Cap Fcs Cl A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-9.49%
ONCT - FULC
55%
Loosely correlated
+2.70%
SLS - FULC
48%
Loosely correlated
+3.94%
ANNX - FULC
40%
Loosely correlated
-3.32%
VRDN - FULC
39%
Loosely correlated
-6.93%
MLTX - FULC
34%
Loosely correlated
-6.99%
More

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with FATE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
-6.93%
FATE - VRDN
50%
Loosely correlated
-2.88%
ALLO - VRDN
50%
Loosely correlated
-7.72%
CRBU - VRDN
48%
Loosely correlated
-4.78%
ABCL - VRDN
46%
Loosely correlated
-3.99%
ALEC - VRDN
46%
Loosely correlated
-17.21%
More